BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7169577)

  • 1. [Evaluation of the routes of administration of a streptococcal preparation, OK-432--with special reference to augmentation of the natural killer cell activity].
    Hosoi J; Wakasugi H; Miyata M; Minato N; Imai M
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2044-55. PubMed ID: 7169577
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunotherapy of non-resectable or recurrent cancer with a streptococcal preparation, OK-432--changes in immunologic parameters and evaluation of the periods of survival following intradermal and intramuscular injections].
    Hanaue H; Nomoto S; Seto A; Kimura T; Kutsuna T; Takeuchi T; Yoshizaki S
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):1975-85. PubMed ID: 7169568
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vivo augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432: characterization of effector cells and induction of interferon in sera (author's transl)].
    Wakasugi H; Miyata M; Morioka Y; Oshimi K; Kasahara T; Takahashi K; Saito M; Ebina T
    Nihon Gan Chiryo Gakkai Shi; 1981 Jun; 16(3):433-46. PubMed ID: 7320603
    [No Abstract]   [Full Text] [Related]  

  • 4. [Oral administration of streptococcal preparation "OK 432"--the 4th report: augmentation of in vitro anti-tumor immune responses of mice with transplanted cecal tumor].
    Tsuchitani T; Kodama H; Tobe T; Nio Y; Kan N; Inamoto T
    Nihon Gan Chiryo Gakkai Shi; 1984 Oct; 19(9):2179-87. PubMed ID: 6530585
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental study of oral administration of streptococcal preparation "OK-432". The third report: its enhancing effects on natural killer activity and lymphoproliferative response to mitogens of mouse mesenteric lymph node].
    Nio Y; Inamoto T; Kan N; Hori T; Nakayama N; Yamasaki N; Hikasa Y; Tsuchitani T; Ban S; Nagai T
    Nihon Gan Chiryo Gakkai Shi; 1984 May; 19(4):803-10. PubMed ID: 6491430
    [No Abstract]   [Full Text] [Related]  

  • 6. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of various administration routes of the streptococcal preparation, OK-432, with regard to their in vivo effect by lymphocytes proliferation assay].
    Kimura Y; Toki H; Okabe K; Fujii M; Tamai M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):95-100. PubMed ID: 3942400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The oral administration of OK-432. The 5th report: the effects on the lymphoproliferative response and natural killer cell activity in mice with transplanted cecal tumors].
    Nio Y; Inamoto T; Hori T; Kan N; Tsuchitani T; Kodama H; Tobe T; Ohgaki K
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):597-608. PubMed ID: 4056544
    [No Abstract]   [Full Text] [Related]  

  • 9. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
    Kobayashi G
    Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):68-76. PubMed ID: 2314383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of pulmonary metastasis in mice by OK-432--MCT emulsion administrated enterally].
    Masuyama K; Tazawa K; Kasagi T; Yamashita I; Ishizawa S; Fujimaki M; Ochiai H; Niwayama S; Matsui H
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1300-6. PubMed ID: 3230345
    [No Abstract]   [Full Text] [Related]  

  • 11. Intratumoral administration of streptococcal preparation (OK-432) to advanced pancreatic cancer.
    Kodama M; Tanaka T
    Hiroshima J Med Sci; 1983 Jun; 32(2):167-71. PubMed ID: 6618899
    [No Abstract]   [Full Text] [Related]  

  • 12. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.
    Oshimi K; Kano S; Takaku F; Okumura K
    J Natl Cancer Inst; 1980 Dec; 65(6):1265-9. PubMed ID: 7001124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of immunological responses and survival periods in cancer patients treated with intradermal and intramuscular injection of the streptococcal preparation OK-432.
    Hanaue H; Kurosawa T; Yasuda H; Yoshizaki S; Nomoto SN; Takada T; Shikata J
    Keio J Med; 1984 Apr; 33(1):17-27. PubMed ID: 6482140
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of intradermal administration of streptococcal preparation OK-432 on interferon and natural killer cell activities in patients with oral cancer.
    Sato M; Yoshida H; Yanagawa T; Yura Y; Urata M; Atsumi M; Hayashi Y; Takegawa Y
    Int J Oral Surg; 1984 Feb; 13(1):7-15. PubMed ID: 6203858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
    Nio Y; Ohgaki K; Henmi K; Kan N; Inamoto T; Tsuchitani T; Kodama H; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):728-34. PubMed ID: 6752308
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
    Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local immunotherapy for cancer].
    Hattori T; Niimoto M; Toge T; Hamamoto S; Seto Y; Kameda A; Tomoda S
    Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1157-61. PubMed ID: 6503978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
    Hayashi Y; Torisu M
    Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of malignant ascites. I. Clinical studies on intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
    Katano M
    Fukuoka Igaku Zasshi; 1981 Oct; 72(10):532-42. PubMed ID: 7327498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.